Quoin Pharmaceuticals, Ltd.QNRXNASDAQ
Loading
SG&A Expenses Over TimeStrong
Percentile Rank56
3Y CAGR+9.6%
5Y CAGR+31.4%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+9.6%/yr
vs +1.7%/yr prior
5Y CAGR
+31.4%/yr
Recent deceleration
Acceleration
+7.9pp
Accelerating
Percentile
P56
Within normal range
vs 5Y Ago
3.9x
Strong expansion
Streak
2 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $5.93M | -2.4% |
| 2023 | $6.07M | -7.8% |
| 2022 | $6.58M | +46.3% |
| 2021 | $4.50M | +215.6% |
| 2020 | $1.43M | -5.9% |
| 2019 | $1.51M | -81.0% |
| 2018 | $7.97M | +89.5% |
| 2017 | $4.20M | -47.2% |
| 2016 | $7.97M | +649.1% |
| 2015 | $1.06M | - |